Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$653,687,004
+$123,712,773 QoQ
Shares Held
544,998
-5.4% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#118
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KBC Group NV holds $2,157,048,254 across 10 Drug Manufacturers - General names. LLY ranks #1 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
544,998 | $653,687,004 | |
| 2 | JNJ |
Johnson & Johnson
|
1,322,168 | $335,791,005 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,264,357 | $245,712,249 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,644,035 | $207,707,380 | |
| 5 | PFE |
Pfizer Inc
|
8,327,265 | $200,520,541 | |
| 6 | ABBV |
AbbVie Inc.
|
672,932 | $169,336,607 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,131,286 | $145,370,250 | |
| 8 | AMGN |
Amgen Inc
|
382,676 | $138,574,632 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $653,687,004 | 544,998 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $529,974,231 | 576,203 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $756,593,059 | 704,017 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $527,912,070 | 691,890 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $475,019,855 | 609,367 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $458,117,410 | 554,682 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $454,714,948 | 589,009 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $501,295,858 | 565,835 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $563,682,343 | 622,592 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $372,838,106 | 479,251 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $334,826,331 | 574,395 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $295,307,627 | 549,788 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $302,932,470 | 645,939 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $194,432,727 | 566,166 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $255,234,494 | 697,667 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $257,903,635 | 797,599 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $195,974,986 | 604,432 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $191,101,859 | 667,325 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $202,676,148 | 733,749 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $129,107,274 | 558,785 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $115,847,695 | 504,739 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $101,721,621 | 544,490 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $108,819,743 | 644,514 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $48,354,729 | 326,677 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $40,169,263 | 244,666 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $55,929,822 | 403,185 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||